Vischer advised FimmCyte, a Swiss biotech developing targeted immunotherapies for chronic fibro-inflammatory diseases, in connection with its research collaboration and option-to-license agreement with Gedeon Richter, a pharmaceutical company specialised in women’s health, with headquarters in Hungary. Within the new collaboration, FimmCyte will conduct joint research and development activities with Gedeon Richter, which will have global […]